Insights On Pharmaceutical Packaging
-
A Robust Extractables Data Package Helps Drive Patient Safety
10/1/2024
Complex drug product formulations are more common, so it is imperative to have a deeper knowledge of extractables to understand risks associated with potential interactions between packaging and product.
-
How To Optimize Labeling In A Pharmaceutical Environment
5/29/2025
Accurate, readable pharmaceutical labels are crucial. Learn to navigate considerations like printing, application tolerances, and inspection to select the right machinery for your production environment.
-
Expanding Home-Based Care With A Next-Gen On-Body Delivery System
10/20/2023
As on-body delivery systems (OBDSs) enable the shift to patient-centric treatment, manufacturers must optimize the device and therapy formulation to minimize the risks and increase adherence.
-
Meeting Annex 1: A Proactive Approach To Regulatory Compliance
3/4/2025
It was imperative for a large European CMO that produces multiple biologic drugs to select the right product quality and value for each customer to comply with the August 2023 revision to the EU GMP Annex 1.
-
Vial Containment Systems Based On Elastomer 4031/45 Gray
10/1/2024
Examine the results of two, two-year studies that indicate good container closure integrity performance that can be achieved with stoppers of a given elastomer, independent of configuration.
-
Understanding Modern Storage Tank Design And Fabrication
7/28/2025
Industries rely on advanced storage tanks and pressure vessels to safely manage liquids, gases, and powders. Discover how custom-engineered solutions can enhance efficiency, safety, and compliance.
-
Characterizing The E&L Profile Of Stoppers For Drug Stability
6/11/2024
The significance of E&L testing lies in its ability to identify potential risks associated with the use of containers and packaging materials in the pharmaceutical industry.
-
3D Screen Printing: Enabling A New Generation Of Complex Formulations
3/17/2025
Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.
-
Achieving EU GMP Annex 1 Compliance For Contamination Control
3/4/2025
Gain insight into three areas that have been key in ensuring a robust contamination control strategy to help ensure compliance with the updated Annex 1 regulation: planning, people, and products.
-
Lifecycle Planning For Containment And Delivery Of Biologics Drug Products
6/20/2024
Read more about trends in the biologics market that could impact the lifecycle strategies for your drug product and steps you can take around drug packaging early in development.